vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and IDEX Corporation (IEX). Click either name above to swap in a different company.

IDEX Corporation is the larger business by last-quarter revenue ($398.4M vs $292.2M, roughly 1.4× Cellebrite DI Ltd.). IDEX Corporation runs the higher net margin — 30.1% vs -103.5%, a 133.6% gap on every dollar of revenue. IDEX Corporation produced more free cash flow last quarter ($86.0M vs $60.8M). Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs -29.4%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.

CLBT vs IEX — Head-to-Head

Bigger by revenue
IEX
IEX
1.4× larger
IEX
$398.4M
$292.2M
CLBT
Higher net margin
IEX
IEX
133.6% more per $
IEX
30.1%
-103.5%
CLBT
More free cash flow
IEX
IEX
$25.2M more FCF
IEX
$86.0M
$60.8M
CLBT
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
-29.4%
IEX

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
CLBT
CLBT
IEX
IEX
Revenue
$292.2M
$398.4M
Net Profit
$-302.3M
$120.0M
Gross Margin
84.6%
99.9%
Operating Margin
14.1%
43.3%
Net Margin
-103.5%
30.1%
Revenue YoY
16.7%
Net Profit YoY
25.7%
EPS (diluted)
$-1.50
$1.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
IEX
IEX
Q2 26
$398.4M
Q1 26
$407.7M
Q4 25
$899.1M
Q3 25
$292.2M
$878.7M
Q2 25
$220.8M
$865.4M
Q1 25
$89.6M
$814.3M
Q4 24
$862.9M
Q3 24
$232.1M
$798.2M
Net Profit
CLBT
CLBT
IEX
IEX
Q2 26
$120.0M
Q1 26
$128.3M
Q4 25
$128.3M
Q3 25
$-302.3M
$127.8M
Q2 25
$36.9M
$131.6M
Q1 25
$-71.4M
$95.5M
Q4 24
$123.2M
Q3 24
$119.1M
Gross Margin
CLBT
CLBT
IEX
IEX
Q2 26
99.9%
Q1 26
94.9%
Q4 25
43.1%
Q3 25
84.6%
44.5%
Q2 25
84.1%
45.3%
Q1 25
85.2%
45.3%
Q4 24
42.5%
Q3 24
83.5%
44.3%
Operating Margin
CLBT
CLBT
IEX
IEX
Q2 26
43.3%
Q1 26
45.0%
Q4 25
20.4%
Q3 25
14.1%
21.1%
Q2 25
12.1%
21.7%
Q1 25
10.3%
17.4%
Q4 24
19.2%
Q3 24
7.9%
21.0%
Net Margin
CLBT
CLBT
IEX
IEX
Q2 26
30.1%
Q1 26
31.5%
Q4 25
14.3%
Q3 25
-103.5%
14.5%
Q2 25
16.7%
15.2%
Q1 25
-79.7%
11.7%
Q4 24
14.3%
Q3 24
14.9%
EPS (diluted)
CLBT
CLBT
IEX
IEX
Q2 26
$1.61
Q1 26
$1.71
Q4 25
$1.71
Q3 25
$-1.50
$1.70
Q2 25
$0.15
$1.74
Q1 25
$-0.36
$1.26
Q4 24
$1.61
Q3 24
$-0.35
$1.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
IEX
IEX
Cash + ST InvestmentsLiquidity on hand
$191.7M
$586.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$336.0M
$4.0B
Total Assets
$690.6M
$6.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
IEX
IEX
Q2 26
$586.2M
Q1 26
$580.0M
Q4 25
$580.0M
Q3 25
$191.7M
$593.8M
Q2 25
$326.1M
$568.2M
Q1 25
$191.7M
$594.1M
Q4 24
$620.8M
Q3 24
$189.5M
$633.2M
Total Debt
CLBT
CLBT
IEX
IEX
Q2 26
Q1 26
Q4 25
$1.8B
Q3 25
$1.9B
Q2 25
$1.9B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.1B
Stockholders' Equity
CLBT
CLBT
IEX
IEX
Q2 26
$4.0B
Q1 26
$4.0B
Q4 25
$4.0B
Q3 25
$336.0M
$4.0B
Q2 25
$408.4M
$4.0B
Q1 25
$336.0M
$3.9B
Q4 24
$3.8B
Q3 24
$34.2M
$3.8B
Total Assets
CLBT
CLBT
IEX
IEX
Q2 26
$6.9B
Q1 26
$6.9B
Q4 25
$6.9B
Q3 25
$690.6M
$7.0B
Q2 25
$787.4M
$6.9B
Q1 25
$690.6M
$6.8B
Q4 24
$6.7B
Q3 24
$532.9M
$7.0B
Debt / Equity
CLBT
CLBT
IEX
IEX
Q2 26
Q1 26
Q4 25
0.45×
Q3 25
0.48×
Q2 25
0.46×
Q1 25
0.50×
Q4 24
0.52×
Q3 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
IEX
IEX
Operating Cash FlowLast quarter
$66.2M
Free Cash FlowOCF − Capex
$60.8M
$86.0M
FCF MarginFCF / Revenue
20.8%
21.6%
Capex IntensityCapex / Revenue
1.8%
4.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$172.1M
$654.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
IEX
IEX
Q2 26
Q1 26
Q4 25
$209.5M
Q3 25
$66.2M
$203.5M
Q2 25
$53.5M
$161.7M
Q1 25
$10.0M
$105.7M
Q4 24
$172.6M
Q3 24
$58.2M
$205.3M
Free Cash Flow
CLBT
CLBT
IEX
IEX
Q2 26
$86.0M
Q1 26
$189.8M
Q4 25
$189.8M
Q3 25
$60.8M
$188.7M
Q2 25
$47.5M
$146.9M
Q1 25
$8.5M
$91.4M
Q4 24
$157.1M
Q3 24
$55.3M
$191.6M
FCF Margin
CLBT
CLBT
IEX
IEX
Q2 26
21.6%
Q1 26
46.6%
Q4 25
21.1%
Q3 25
20.8%
21.5%
Q2 25
21.5%
17.0%
Q1 25
9.5%
11.2%
Q4 24
18.2%
Q3 24
23.8%
24.0%
Capex Intensity
CLBT
CLBT
IEX
IEX
Q2 26
4.4%
Q1 26
15.6%
Q4 25
2.2%
Q3 25
1.8%
1.7%
Q2 25
2.7%
1.7%
Q1 25
1.7%
1.8%
Q4 24
1.8%
Q3 24
1.3%
1.7%
Cash Conversion
CLBT
CLBT
IEX
IEX
Q2 26
Q1 26
Q4 25
1.63×
Q3 25
1.59×
Q2 25
1.45×
1.23×
Q1 25
1.11×
Q4 24
1.40×
Q3 24
1.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

IEX
IEX

Segment breakdown not available.

Related Comparisons